html5-img
1 / 22

emergentec biodevelopment GmbH Rathausstrasse 5/3 A-1010 Vienna, Austria emergentec

in-silico workflows for biomarker and target identification. emergentec biodevelopment GmbH Rathausstrasse 5/3 A-1010 Vienna, Austria www.emergentec.com. Bernd Mayer bernd.mayer@emergentec.com. differential abundance. candidates. explorative. hypothesis driven. functional

dorit
Download Presentation

emergentec biodevelopment GmbH Rathausstrasse 5/3 A-1010 Vienna, Austria emergentec

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. in-silico workflows for biomarker and target identification emergentec biodevelopment GmbH Rathausstrasse 5/3 A-1010 Vienna, Austria www.emergentec.com Bernd Mayer bernd.mayer@emergentec.com

  2. differential abundance candidates explorative hypothesis driven functional interpretation from Liu et al. 2006Cancer Cell 9(4):245-7 background emergentec biodevelopment is developing and applying computational tools for biomarker and target identification.

  3. definitions WORKFLOW Framework for a progression of computational steps, sequentially or in parallel, for identifying biomarkers and targets. BIOMARKER A compound (gene, RNA, protein, metabolite, etc.) with high sensitivity and specificity for a given cellular status. TARGET A compound with biomarker characteristics which can be addressed by therapy means for altering a given cellular status.

  4. ELISA epitope VACCINE THER. AB epitope antibody antibody AB in IHC biomarkers & application

  5. to candidates derived from a functional context from Bornholdt et al. 2005Science 310(5747):449-51 the trend ...from descriptive lists of candidates

  6. agenda I. Sequential (iterative) workflows II. Parallel (integrated) workflows

  7. omics selection genomics transcriptomics proteomics metabolomics ... expression co-regulation interaction networks functional pathways ... verification PCR ELISA, IHC, siRNA ... characterization structure location determinants ... sequential procedure

  8. focus on SE/SP 41,121 features • 1. Filter genes • Quality Filter (80%) 1. • 2. Replace missing values • KNN – Algorithm 2. 16,100 features • 3. Filter genes • Variation Filter (SD > 0.9) 3. 1,081 features • 4. Statistical testing • t-test with maxT correction 4. n candidates

  9. co-regulation analysis network analysis refinement of SE/SP statistical analysis

  10. ID1 ID2 ID3 Detection of coregulation in differential gene expression profiles. P Perco, A Kainz, G Mayer, A Lukas, R Oberbauer, B Mayer, Biosystems 82, 235-247 (2005). co-regulation correct / expand Omics results from statistics

  11. differentially expressed genes Stress Responses and Conditioning Effects in Mesothelial Cells Exposed to Peritoneal Dialysis Fluid. K Kratochwill, M Lechner, Ch Siehs, HC Lederhuber, P Rehulka, M Endemann, DC Kasper, KR Herkner, B Mayer, A Rizzi, Ch Aufricht, Journal of Proteome Research, 8, 1731-1747 (2009). Biomarkers for cardiovascular disease and bone metabolism disorders in chronic kidney disease: A systems biology perspective. P Perco, J Wilflingseder, A Bernthaler, M Wiesinger, M Rudnicki, B Wimmer, A Kainz, A Lukas, G Mayer, B Mayer, R Oberbauer, Journal of Cellular and Molecular Medicine, 12, 1177-1187 (2008). differentially expressed genes genes of a particular functional category protein networks and interpret in the context of PPIs

  12. Machine learning approaches for prediction of linear B-cell epitopes on proteins. J Sollner, B Mayer, Journal of Molecular Recognition 19, 200-208 (2006). Identifying discontinuous antigenic determinants on proteins based on shape complementarities and binding energies. R Rapberger, A Lukas, B Mayer, Journal of Molecular Recognition 20, 113-121 (2007). addressable Workflows for computing subcellular location, PTMs, accessibility, antigenicity, etc. http://taverna.sourceforge.net/

  13. subcellular location co-regulation CCP data set; Schaner et al. 2003; Welsh et al. 2001; conjoint pathways interaction networks candidate protein selection in silico immunogenicity scoring experimental verification example workflow Meta-UP (86) up-regulated genes 3 Meta-UP (192) publication meta-analysis SEREX (81) exp. derived autoantigens Meta-DOWN (106) down-regulated genes 1

  14. and their experimental verification Linking the ovarian cancer transcriptome and immunome. R Rapberger, P Perco, C Sax, T Pangerl, C Siehs, D Pils, A Bernthaler, A Lukas, B Mayer, M Krainer, BMC Systems Biology, 3;2:2. (2008). Identification of a novel melanoma biomarker derived from melanoma-associated endogenous retroviruses. J Humer, A Waltenberger, A Grassauer, M Kurz, J Valencak, R Rapberger, K Wolff, T Muster, B Mayer, H Pehamberger, Cancer Research 66, 1658-1663 (2006). exp. verification interpreting candidates in their context

  15. goals object lists ID1 ID2 ... ... IDn • object dependencies • data consolidation • reduce false positives • derive functional context a parallel approach concept

  16. Ansatz for Dynamical Hierarchies. S Rasmussen, N Baas, B Mayer, M Nilsson, MW Olesen. Artificial Life 7, 329-353 (2001). omicsNET construction No sequential data enrichment, but one-step data integration

  17. omicsNET characteristics Characterization of protein-interaction networks in tumors. Platzer A, Perco P, Lukas A, Mayer B, BMC Bioinformatics. 2007 Jun 27;8:224.

  18. example analysis Rosenwald et al., 2001 Rosenwald et al., 2002 Rosenwald et al., 2002 Rosenwald et al., 2001 Zhan et al., 2002 A dependency graph approach for analysis of differential gene expression profiles. A Bernthaler, I Mühlberger, R Fechete, P Perco, A Lukas, B Mayer Molecular Biosystems2009; June 3 ahead of print

  19. and expanding annotation

  20. in brief Bioinformatics as support / driver for biomarker and target discovery: • Clearcut experimental study designs • Thorough local data management • Integrate the data sources out there with your own (Omics) data • Make use of the public domain analysis workflows • Do not stick with statistics but go for functional context in candidate selection

  21. some tools & databases For data preparation and statistics: R-Bioconductor, MeV, etc. For coregulation: oPOSSUM, CORG, CONFAC, etc. For protein interactions: OPHID, INTACT, etc. For pathways: KEGG, PANTHER, GO, etc. For reference data repositories: arrayExpress, GEO, SMD, Oncomine, Swiss2D Page, etc. For annotation: GeneCards, iHOP, etc. For viewing: Cytoscape, etc. For context analysis: STRING For target characterization: PSORT, PROSITE, SABLE, PSIPRED, etc.

  22. acknowledgements @emergentec Paul Perco and team Johannes Soellner and team Martin Haiduk and team OVCAD SYNLET predictIV Transforming omics data into context: Bioinformatics on genomics and proteomics raw data. Perco P, Rapberger R, Siehs C, Lukas A, Oberbauer R, Mayer G, Mayer B Electrophoresis2006; 27(13):2659-2675. A dependency graph approach for analysis of differential gene expression profiles. Bernthaler A, Mühlberger I, Fechete R, Perco P, Lukas A, Mayer B Molecular Biosystems2009; June 3 ahead of print

More Related